PATENT CLAIM ANALYSIS

Application Number: 15942772
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "210180"]

Abstract:
Compounds of Formula I, as shown below and defined herein: and pharmaceutically acceptable salts, syntheses, intermediates, formulations, and methods of treating diseases including cancer, inflammation, and autoimmune disease mediated at least in part by Bruton's Tyrosine Kinase (BTK).

Claim (Index 7):
The compound according to  claim 1 , which is

Metadata:
- Claim Count in Document: 4.0
- Percentile: 91.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15025654', '16073607', '15374945', '15317323', '14723417']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8018463694700603
- 35 USC 102 Novelty (BERT): 0.5220569912151175
- Combined Prediction Score: 0.773867431644566
- Mean Citation Score: 276.51819
- Max Citation Score: 314.23584
- Similarity Product: 227.396871282692

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test